Interim Review of Safety, Tolerability, and Efficacy From a First-In-Human Phase 1/2a Clinical Study of ICM-203, an Intra-Articular, AAV Gene Therapy for Osteoarthritis
conference contribution
posted on 2024-12-03, 04:15authored byAlison E Heald, Bogdan Solomon, Richard PageRichard Page, Yoenhee Ahn, Young Na Yum, Jayhyuk Myung, Jamie E Collins, Ali Guermazi, Dae-Won Kim
Interim Review of Safety, Tolerability, and Efficacy From a First-In-Human Phase 1/2a Clinical Study of ICM-203, an Intra-Articular, AAV Gene Therapy for Osteoarthritis